Company Filing History:
Years Active: 2014-2017
Title: Innovator Spotlight: Charles Waechter
Introduction
Charles Waechter is a notable inventor based in Lexington, KY, known for his contributions to the field of biotechnology. With a total of two patents to his name, Waechter has made significant strides in the development of bioconjugate vaccines and advanced polysaccharide synthesis.
Latest Patents
Among his latest inventions is a biosynthetic system designed to produce immunogenic polysaccharides in prokaryotic cells. This invention is particularly focused on bioconjugate vaccines that incorporate N-glycosylated proteins. The recombinant prokaryotic biosynthetic system involves nucleic acids encoding an epimerase that synthesizes oligosaccharides or polysaccharides characterized by N-acetylgalactosamine at the reducing terminus. Additionally, his work extends to N-glycosylated proteins featuring this polysaccharide structure and includes an expression system and methods for efficiently producing these proteins.
Career Highlights
Charles Waechter has established his career at Glycovaxyn AG, where he collaborates with a talented team to drive innovations in vaccine development. His expertise in biotechnology has positioned him as a key contributor to advancements in immunogenic research and applications.
Collaborations
One of his prominent collaborators is Michael Wacker, with whom Waechter works closely at Glycovaxyn AG. Their partnership is instrumental in pushing the boundaries of current vaccine technology and exploring new avenues for therapeutic interventions.
Conclusion
Charles Waechter is an exemplary inventor whose work in biotechnology is paving the way for next-generation vaccines. His innovative approaches and collaborations continue to impact the field positively, and his patents are a testament to his dedication and expertise in developing significant biotechnological advancements.